Funded Tech Companies
Rgenta Therapeutics
Rgenta Therapeutics is a leading biopharmaceutical tech company, based in Cambridge. Venture investment and financing was provided by AstraZeneca, Korea Investment Partners and Delos Capital.
Company Overview
Company Name
Rgenta Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
700 Main St. LabCentral
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Rgenta Therapeutics is developing a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology and neurological disorders. Our proprietary platform mines the massive genomics data to identify targetable RNA processing events and design small-molecule glues to modulate the interactions among the spliceosome, regulatory proteins, and RNAs.
Last Transaction
11/29/2022
Financing History
Date
Type
Amount
Management Team
Company Investors
- AstraZeneca
- Korea Investment Partners
- Delos Capital
- Boehringer Ingelheim Venture Fund (Martin Heidecker)
- Legend Star
- Matrix Partners
- Kaitai Capital
Browse more funded tech companies:
Share this article
About Our VC Deals Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs